Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT07270640

Lifestyle Intervention to Improve Twin Pregnancy Outcomes

Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2025-12-16

81

Participants Needed

4

Research Sites

77 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial to is assess the benefits of holistic lifestyle interventions, including nutrition, physical activities, and mindfulness, aiming to reduce preterm birth in twins, potentially revolutionizing twin care globally. An initial integrated pilot study is be conducted to assess and refine the intervention methods. The primary objective of the pilot study is to evaluate feasibility. If deemed feasible, the full study will be implemented, incorporating data from pilot study participants into the main study. Objective of the full study: To evaluate if a multi-component lifestyle extends gestational age at delivery by one week. Additional objective: to evaluate if the intervention positively influences multiple secondary outcomes including pregnancy complications, neonatal and maternal outcomes, and maternal quality of life.

CONDITIONS

Official Title

Lifestyle Intervention to Improve Twin Pregnancy Outcomes

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Provided voluntary written informed consent prior to any randomization or intervention
  • Diagnosed with dichorionic twin pregnancies according to acceptance criteria
  • Recruited before the 14th week of gestation
  • Proficient in Dutch, English, or French
Not Eligible

You will not qualify if you...

  • History of pre-existing diseases or conditions impacting diet, including pre-gestational diabetes, severe heart disease, chronic renal disease, celiac disease, inflammatory bowel disease, or post-bariatric surgery
  • History of pre-existing diseases or conditions limiting physical activity, such as COPD, severe asthma, fibromyalgia, osteoarthritis, chronic pain syndromes, spinal cord injuries, multiple sclerosis, Parkinson's disease, history of stroke, or drug-resistant epilepsy
  • Identified mental vulnerabilities requiring specific care pathways
  • History of mental health disorders including PTSD, anxiety disorders, depressive disorders, bipolar disorder, obsessive-compulsive disorder, schizophrenia, or schizoaffective disorder
  • Inability to give informed consent
  • Lack of knowledge of Dutch, English, or French
  • First trimester diagnosis of severe congenital anomaly in one or both twins
  • First trimester fetal demise of one or both twins
  • Rupture of membranes prior to recruitment
  • Participation in any other interventional study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

CHU Brugmann

Brussels, Belgium, 1020

Not Yet Recruiting

2

Ziekenhuis Oost-Limburg

Genk, Belgium, 3600

Actively Recruiting

3

UZ Leuven

Leuven, Belgium, 3000

Actively Recruiting

4

Hôpital de la Citadelle

Liège, Belgium, 4000

Not Yet Recruiting

Loading map...

Research Team

P

Prof. Dr. Roland Devlieger

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here